Biotechnology Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Biotechnology Contract Manufacturing Market Size, Share & Trends Analysis Report By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services), By Type, By Scale of Operation , By Source, By Molecule, By Therapeutic Area, By Region, And By Segment Forecasts, 2025-2034
報告摘要
The worldwide Biotechnology Contract Manufacturing Market stood at USD 20.5 Bn in 2024, and is projected to reach USD 46.6 Bn by 2034, recording a CAGR of 8.7% from 2025 through 2034.
Biotechnology Contract Manufacturing encompasses key industry insights & findings from the report:
The growing usage of biologics in a variety of therapeutic applications is likely to drive growth in the biotechnology contract manufacturing market. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is driven by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biotechnology Contract Manufacturing Market Snapshot
Chapter 4. Global Biotechnology Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Estimates & Trend Analysis
5.1. By Service, & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service:
5.2.1. Manufacturing
5.2.2. Formulation and Fill-Finish
5.2.3. Packaging and Labeling
5.2.4. Other services
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
6.2.1. Biologic Drug Substance Manufacturing
6.2.2. Biologic Drug Product Manufacturing
Chapter 7. Market Segmentation 3: By Scale of Operation Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Scale of Operation:
7.2.1. Commercial Operations
7.2.2. Clinical Operations
Chapter 8. Market Segmentation 4: By Source Estimates & Trend Analysis
8.1. By Source & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Source:
8.2.1. Mammalian Expression Systems
8.2.2. Non-Mammalian Expression Systems
Chapter 9. Market Segmentation 5: By Molecule Estimates & Trend Analysis
9.1. By Molecule & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Molecule:
9.2.1. Monoclonal Antibodies
9.2.2. Cell Therapy & Gene Therapy
9.2.3. Antibody-Drug Conjugates (ADCs)
9.2.4. Vaccines
9.2.5. Therapeutic Peptides & Proteins
9.2.6. Other Molecule Types
Chapter 10. Market Segmentation 6: By Therapeutic Area Estimates & Trend Analysis
10.1. By Therapeutic Area & Market Share, 2024-2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Therapeutic Area:
10.2.1. Oncology
10.2.2. Autoimmune Diseases
10.2.3. Cardiovascular Diseases
10.2.4. Metabolic Diseases
10.2.5. Infectious Diseases
10.2.6. Neurology
10.2.7. Other Therapeutic Areas
Chapter 11. Biotechnology Contract Manufacturing Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Service, 2021-2034
11.1.2. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
11.1.3. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Scale of Operation, 2021-2034
11.1.4. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Source, 2021-2034
11.1.5. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Molecule, 2021-2034
11.1.6. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.1.7. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, 2021-2034
11.2.2. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, 2021-2034
11.2.3. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
11.2.4. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, 2021-2034
11.2.5. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, 2021-2034
11.2.6. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, 2021-2034
11.2.7. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, 2021-2034
11.3.2. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, 2021-2034
11.3.3. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
11.3.4. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, 2021-2034
11.3.5. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, 2021-2034
11.3.6. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, 2021-2034
11.3.7. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
11.4.2. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
11.4.3. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
11.4.4. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
11.4.5. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, (US$ Million) 2021-2034
11.4.6. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
11.4.7. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
11.5.2. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
11.5.3. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
11.5.4. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
11.5.5. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, (US$ Million) 2021-2034
11.5.6. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
11.5.7. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1 Lonza (Switzerland)
12.2.2 Samsung Biologics (South Korea)
12.2.3 Thermo Fisher Scientific, Inc. (US)
12.2.4 Catalent, Inc. (US)
12.2.5 JSR Corporation (Japan)
12.2.6 WuXi Biologics (China)
12.2.7 AbbVie, Inc. (US)
12.2.8 Boehringer Ingelheim International GmbH (Germany)
12.2.9 Eurofins Scientific (Luxembourg)
12.2.10 GenScript Biotech Corporation (US)
12.2.11 AGC, Inc. (Japan)
12.2.12 FUJIFILM Holding Corporation (Japan)
12.2.13 Merck KgaA (Germany)
12.2.14 Stelis
12.2.15 Recipharm Ab
12.2.16 Emergent
12.2.17 Shanghai Fosun Pharmaceutical Co., Ltd.
12.2.18 Lotte Biologics
12.2.19 Hepalink Group
12.2.20 Curia Global, Inc.
12.2.21 Jrs Pharma
12.2.22 Minapharm Pharmaceuticals
12.2.23 Rentschler Biopharma Se
12.2.24 Avid Bioservices, Inc.
12.2.25 Abzena Ltd.
12.2.26 Polyplus Transfection
12.2.27 Midas Pharma GMBH
12.2.28 Mabplex International Co., Ltd.
12.2.29 Asahi Kasei Corporation
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們